Soleno Therapeutics, Inc. (NASDAQ: SLNO)
| Pre-Market |
Intra-Day |
After-Hours |
| - (- / -%) |
52.67 (-0.11 / -0.21%) |
52.77 (0.10 / 0.19%) |
| - |
20-Apr 16:00 |
20-Apr 18:09 |
Sector:
Healthcare || Industry:
Biotechnology
| Previous Close |
52.78 |
Year Low |
29.43 |
| Open |
52.75 |
Year High |
90.32 |
| Day Low |
52.65 |
Price Avg 50 |
40.07 |
| Day High |
52.76 |
Price Avg 200 |
55.82 |
| Volume |
2.69 M |
Market Cap |
2.72 B |
News
Analysis
| SLNO |
-0.21 |
0.06 |
58.55 |
20.44 |
-19.53 |
-23.59 |
Earnings
| 02/25/2026 |
AMC |
SLNO |
Soleno Therapeutics |
Q4 2025 |
EPS |
0.71 |
0.80 |
12.68 |
-1.27 |
|
|
| 02/25/2026 |
AMC |
SLNO |
Soleno Therapeutics |
Q4 2025 |
REV |
88.55 M |
91.73 M |
3.59 |
|
0.00 |
|
| 11/04/2025 |
AMC |
SLNO |
Soleno Therapeutics |
Q3 2025 |
EPS |
0.05 |
0.47 |
840.00 |
-1.83 |
|
|
| 11/04/2025 |
AMC |
SLNO |
Soleno Therapeutics |
Q3 2025 |
REV |
48.10 M |
66.00 M |
37.23 |
|
|
|
| 08/06/2025 |
AMC |
SLNO |
Soleno Therapeutics |
Q2 2025 |
EPS |
-0.90 |
-0.09 |
90.00 |
-0.57 |
84.20 |
|
| 08/06/2025 |
AMC |
SLNO |
Soleno Therapeutics |
Q2 2025 |
REV |
3.91 M |
|
0.00 |
|
0.00 |
|
| 05/07/2025 |
AMC |
SLNO |
Soleno Therapeutics |
Q1 2025 |
EPS |
-0.62 |
-0.95 |
-53.23 |
-0.59 |
-61.00 |
Healthcare / Biotechnology |
| 05/07/2025 |
AMC |
SLNO |
Soleno Therapeutics |
Q1 2025 |
REV |
13.93 M |
|
0.00 |
|
0.00 |
Healthcare / Biotechnology |
Outlooks
| 01/12/2026 |
06:00 PM |
SLNO |
Soleno Therapeutics |
Q4 2025 |
REV |
$86.32 M |
$90.00 M ~ $92.00 M |
|
|
|
|
0.00 |
91.00 |
|
5.42 |
|
|
|
|
43,687 |
|
|
|
* Growth at Outlook Mid-point against Estimate
Ratings
| 04/08/2026 |
SLNO |
HC Wainwright & Co. |
Neutral |
Buy |
Downgrade |
| 04/07/2026 |
SLNO |
TD Cowen |
Hold |
Buy |
Downgrade |
| 04/07/2026 |
SLNO |
Wolfe Research |
Peer Perform |
Outperform |
Downgrade |
| 04/06/2026 |
SLNO |
Cantor Fitzgerald |
Neutral |
Overweight |
Downgrade |
| 03/18/2026 |
SLNO |
Oppenheimer |
Outperform |
Outperform |
Maintain |
| 03/04/2026 |
SLNO |
HC Wainwright & Co. |
Buy |
Buy |
Maintain |
| 02/27/2026 |
SLNO |
Wells Fargo |
Overweight |
Overweight |
Maintain |
| 02/26/2026 |
SLNO |
TD Cowen |
Buy |
Buy |
Maintain |
| 01/20/2026 |
SLNO |
HC Wainwright & Co. |
Buy |
Buy |
Maintain |
| 01/20/2026 |
SLNO |
Wells Fargo |
Overweight |
Overweight |
Maintain |
Dividends
Sign-Up to see the full list of CATALYSTS in the Calendars
<<Back to Stock Screener>>